# Multiple Myeloma Research Foundation

Multiple Myeloma Research Foundation is a Foundation based in Norwalk, United States.

## Overview

- **Organization type:** Foundation
- **Headquarters:** Norwalk, United States
- **Region:** North America
- **Address:** Norwalk, CT, United States
- **Founded:** 1998
- **Assets under management:** Undisclosed
- **Website:** themmrf.org
- **LinkedIn:** https://www.linkedin.com/company/multiple-myeloma-research-foundation

## Regulatory record

- **Reports private funds:** No

## About

The Multiple Myeloma Research Foundation (MMRF) is the largest nonprofit in the world focused on accelerating a cure for each and every myeloma patient.

## Sectors

- Healthcare Services
- Biotech & Pharma
- Precision Medicine
- Clinical Data & Analytics
- Patient Advocacy

## Offices

- Cambridge, MA, United States
- La Jolla, CA, United States

## People

- Kathy Giusti — Co-Founder
- Karen Giusti — Co-Founder

## Questions

### Who runs investment decisions at the MMRF?

The MMRF is led by an executive leadership team and a board of directors composed of industry leaders and investors. Specific investment decisions, particularly for the Myeloma Investment Fund, are guided by the foundation's Scientific Advisory Board and internal research leadership, though named individuals are not publicly disclosed beyond the executive team.

### How does the MMRF source proprietary deal flow?

The MMRF sources investment opportunities through its deep network of researchers, clinicians, and industry partners in the multiple myeloma field. Its Myeloma Investment Fund (MIF) targets biotechnology companies with promising new therapies, leveraging the foundation's comprehensive CoMMpass Study and patient data to identify high-impact interventions.

### Is the MMRF structured as a foundation or does it operate more like a venture firm?

The MMRF operates as a nonprofit medical research foundation, but its Myeloma Investment Fund (MIF) functions similarly to a venture capital arm, making equity-style investments in early-stage biotech companies. This hybrid structure allows it to directly fund research while also supporting commercial drug development.

### What investment stages does the MMRF typically target?

The MMRF primarily targets early-stage and translational research through its Myeloma Investment Fund, focusing on biotechnology companies developing novel multiple myeloma treatments. It also supports clinical trials at various stages, including Phase I, II, and III, through its research grants and partnerships.

### What is the MMRF's known posture on co-investments alongside external partners?

The MMRF collaborates with pharmaceutical companies, academic institutions, and other research foundations on clinical trials and data-sharing initiatives. Its CoMMpass Study, for example, is a collaborative effort with multiple partners to share genomic and clinical data, but the foundation does not publicly disclose co-investment structures in its MIF portfolio.

## Related profiles

- [Fulcrum 2020](https://altss.com/profile/fulcrum-2020)
- [Clough Capital Partners](https://altss.com/profile/clough-capital-partners)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/multiple-myeloma-research-foundation

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology